Company Overview of Sequoia Capital
Sequoia Capital is a private equity and venture capital firm specializing in incubation, seed, start-up, early, and growth, emerging growth, mature, mid-venture, late-venture, and PIPE investments in private and public companies. The firm seeks to invest in all sectors with a focus on energy, financials and financial services, healthcare and healthcare services, Internet, mobile, outsourcing, and technology. Within energy, the firm invests in alternative energy, conventional energy, energy efficiency, energy storage, and energy services markets. Within financials and financial services, it invests in banking, brokerage, payments, and enabling technology. Within healthcare and healthcare serv...
3000 Sand Hill Road
Menlo Park, CA 94025
Founded in 1972
Key Executives for Sequoia Capital
Compensation as of Fiscal Year 2013.
Sequoia Capital Key Developments
UnitedLex Reportedly Up For Sale
Mar 14 14
Helion Venture Partners, LLC, Sequoia Capital and Canaan Partners are reportedly looking to sell UnitedLex Corporation. Helion Venture, Sequoia Capital and Canaan Partners have reportedly mandated Credit Suisse to look for a buyer for the company with a hybrid offshoring model, people familiar with the matter said. Investment bankers have approached strategic buyers like Huron Consulting Group Inc. (NasdaqGS:HURN), Copal Partners and private equity buyout funds with the sale offer, sources mentioned earlier said. Pavan Vaish, global Chief Operating Officer of UnitedLex, said the news was inaccurate, “Given where we are in terms of delivered performance and the fact that we continue to see significant business growth in the coming year".
Quick Heal Seeks IPO
Mar 4 14
Quick Heal Technologies (P) Ltd. is planning an initial public offering (IPO) in India between December 2014 to January 2015. Kailash Katkar, Chief Executive Officer of Quick Heal said, “We are finalising plans for IPO in December-January to fund our expansion into new overseas markets and launching more products.” Quick Heal is is yet to finalise size of the IPO and dilution percentage of promoters holding and Sequoia Capital.
Sources Say Sequoia Planning To Exit GVK Biosciences
Mar 3 14
Sequoia Capital is planning to exit GVK Power and Infrastructure Limited’s (BSE:532708) GVK Biosciences Private Limited. According to three people close to the matter, Sequoia has appointed Avendus to look for buyers for its 20% stake in GVK. An investment banker close to the matter stated, “The fund is looking at earning more than three times returns on its investment in the company. Currently, its stake is being valued at around $50 million.” Another banker close to the matter added, “The company is looking at either a strategic investor or a buyout fund. The promoters too could look at selling further stake to raise capital for the company's growth plans.” Spokesperson for GVK Bio did not respond to an emailed query from Economic Times. Te report added that Abhay Pandey, Managing Director and in charge of investment in GVK Bio for Sequoia, too didn't respond to an emailed query.
Similar Private Companies By Industry
Recent Private Companies Transactions